License Required
Compare
View Alternative
Menveo® Meningitis Vaccine for Ages 2 Months to 55 Years - Meningococcal ACWY Vaccine
58160095509 | USAMP#65471671
container type
Single-Dose Vial
volume
0.5 mL
dosage form
Injection
strength
10 mcg - 5 mcg / 0.5 mL
Product Description
- Protects against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
- Approved for individuals from 2 months to 55 years of age.
- Preservative-free, oligosaccharide diphtheria CRM197 conjugate vaccine.
- Comes in a single-dose vial of 0.5 mL, requiring reconstitution of two components before administration.
- Manufactured by GlaxoSmithKline, ensuring high standards of safety and efficacy.
Product Specification
Manufacturer SKU
58160095509
NDC Code
58160095509
Manufacturer
Glaxo Smith Kline
Brand
Menveo®
USAMP SKU
USAMP#65471671
Application
Meningitis Vaccine
UNSPSC Code
51201610
Country Of Origin
Unknown
Product Dating
USAMP Acceptable Dating: we will ship >= 90 days
Storage Requirements
Requires Refrigeration
User
Indicated for People 2 Months Through 55 Years of Age
Volume
0.5 mL
Strength
10 mcg - 5 mcg / 0.5 mL
Container Type
Single-Dose Vial
Type
Intramuscular
Dosage Form
Injection
Generic Drug Code
28272
Generic Drug Name
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free
More Information
Cart
Total Price
Cart
Access Exclusive Bulk Deals!
Log in to shop smarter with better pricing, more options, and bulk savings.
Starting from
$1,111.65
UOM
Qty
1
